Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
AMINOHETEROARYL KINASE INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2023/226920
Kind Code:
A1
Abstract:
Provided herein are novel compounds (e.g., Formula I or II), pharmaceutical compositions, and methods of using related to cyclin dependent kinases (CDKs). The compounds herein are typically CDK inhibitors, which can be used for treating a variety of diseases or disorders, such as cancer.

More Like This:
JP63586396-membered heterocyclic derivatives and pharmaceutical compositions containing them
JP5748737Etravirine and nicotinamide co-crystals
WO/2014/100748HETEROARYL COMPOUNDS AND USES THEREOF
Inventors:
CHENG DAI (CN)
YUE QIMING (CN)
ZENG SEN (CN)
HE ZHIXIANG (CN)
ZHOU XIAOBO (CN)
ZHOU YANG (CN)
XIE ZEQIANG (CN)
YIN XIAOHANG (CN)
DING QIANG (CN)
Application Number:
PCT/CN2023/095466
Publication Date:
November 30, 2023
Filing Date:
May 22, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ANRUI BIOMEDICAL TECH GUANGZHOU CO LTD (CN)
International Classes:
C07D239/48; A61K31/505; A61P35/00; C07D403/12; C07D405/12
Domestic Patent References:
WO2022111621A12022-06-02
WO2022166793A12022-08-11
WO2002096887A12002-12-05
WO2002096888A12002-12-05
WO2006087230A12006-08-24
WO2010046034A12010-04-29
Attorney, Agent or Firm:
SINO-CREATIVITY INTELLECTUAL PROPERTY LAW FIRM (CN)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: ELECTRONIC DEVICE

Next Patent: BISPECIFIC CHIMERIC ANTIGEN RECEPTOR TARGETING BCMA-CD19 AND APPLICATION THEREOF